Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia Protocol
Charlene Rae(McMaster University), Ronald D. Barr(McMaster University), Eric Larsen(University of Massachusetts Chan Medical School), Eleanor Pullenayegum(University of Toronto), David Feeny(Impact), Uma H. Athale(McMaster University), Lewis B. Silverman(Columbia University Irving Medical Center), Bruno Michon(Centre hospitalier universitaire de Québec), Stephen E. Sallan, Caroline Laverdière(Centre Hospitalier Universitaire Sainte-Justine), Kara M. Kelly(Roswell Park Comprehensive Cancer Center), Luis A. Clavell(San Juan City Hospital), William Furlong(United Utilities (United Kingdom)), Rana Couchman(Centre for Nursing Innovation)
Cited by 7
Related Papers
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System
|Medical Care|2002|1.3k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|920
Multiattribute Utility Function for a Comprehensive Health Status Classification System
|Medical Care|1996|905